在非小细胞肺癌 (NSCLC) 中新兴的向疗法
Syeda A Mina1, Mohamed Shanshal2, Konstantinos Leventakos2
1Division of Hematology and Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Cancers
|February 13, 2025
概括
本综述涵盖了针对EGFR和ALK改变的非小细胞肺癌 (NSCLC) 的新型KRAS导向疗法和标准治疗方法. 它还探讨了MET,HER2,RET,ROS1,FGFR和TROP-2等新兴点,以改善肺癌护理.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 向疗法显著改善了非小细胞肺癌 (NSCLC) 的存活率.
- 在识别和向致癌驱动因素方面取得的快速进展,在保持治疗选择的最新状态方面提出了挑战.
研究的目的:
- 审查肺癌中可行的治疗目标的新兴前景.
- 为NSCLC中各种遗传变异提供关于新型治疗策略的最新信息.
主要方法:
- 关于NSCLC向治疗的最新进展的文献综述.
- 专注于特定的癌症驱动因素,包括KRAS,EGFR,ALK,MET,HER2,RET,ROS1,FGFR和TROP-2.
主要成果:
- 讨论新的KRAS导向疗法,包括非G12C突变,泛RAS和RAS-GTP抑制剂.
- 目前对EGFR和ALK变异性NSCLC的护理标准的概述,以及预期的新疗法.
- 在NSCLC治疗中探索新兴点,如MET,HER2,RET,ROS1,FGFR和TROP-2.
结论:
- 针对NSCLC的向治疗领域正在迅速发展,为患者提供了新的希望.
- 针对新的途径和抗药机制,如TROP-2,对于未来的治疗策略至关重要,特别是在后向治疗环境中.
关键词:
在ALK5中,ALK是5.非洲农业基金4 4在HER2 8 8中.克拉斯 6 克拉斯 6营商环境规则7 营商环境规则在NSCLC 2中.在RET 9中,使用RET 9.在TROP-2 10 10 10肺癌 3 肺癌 3 肺癌 3 肺癌针对性的治疗方法 1 针对性的治疗方法 1更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.9K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
